Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

The Metabolism of Clopidogrel Is Catalyzed by Human Cytochrome P450 3A and Is Inhibited by Atorvastatin

Thomas A. Clarke and Lucy A. Waskell
Drug Metabolism and Disposition January 2003, 31 (1) 53-59; DOI: https://doi.org/10.1124/dmd.31.1.53
Thomas A. Clarke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucy A. Waskell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 31 no. 1 53-59
DOI 
https://doi.org/10.1124/dmd.31.1.53
PubMed 
12485953

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 22, 2002
  • Accepted September 30, 2002
  • Published online January 1, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Thomas A. Clarke1 and
  2. Lucy A. Waskell1
  1. 1Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan (T.C., L.W.); 2Veterans Affairs Medical Center, Ann Arbor, Michigan (L.W.)
  1. Lucy Waskell, Department of Anesthesiology, University of Michigan, VA Medical Center 11R, 2215 Fuller Road, Ann Arbor, MI 48105.Waskell{at}umich.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2002 to February 2021

AbstractFullPdf
Dec 200281102136
Jan 200377279236
Feb 200341173152
Mar 200335195114
Apr 20032415286
May 20032410164
Jun 2003317673
Jul 2003297445
Aug 2003497049
Sep 2003547556
Oct 2003469361
Nov 2003467255
Dec 2003253738
Jan 2004346995
Feb 2004378090
Mar 2004289487
Apr 2004307276
May 2004287153
Jun 2004258464
Jul 2004258555
Aug 2004248460
Sep 20043212758
Oct 20044811961
Nov 20043611860
Dec 20043910562
Jan 20054512255
Feb 2005309855
Mar 20054810468
Apr 2005237547
May 2005247873
Jun 2005279766
Jul 2005228362
Aug 2005208160
Sep 20052211454
Oct 2005349362
Nov 20054811762
Dec 2005359759
Jan 20063214554
Feb 20063012554
Mar 20063014360
Apr 20063011443
May 20065710062
Jun 2006498956
Jul 2006637849
Aug 2006456037
Sep 2006577257
Oct 2006859884
Nov 200610511992
Dec 2006416841
Jan 2007627680
Feb 2007639056
Mar 2007619775
Apr 2007707761
May 2007458953
Jun 2007375835
Jul 2007506850
Aug 2007529274
Sep 2007677065
Oct 2007528054
Nov 2007546265
Dec 2007235445
Jan 20085311996
Feb 2008488265
Mar 2008559262
Apr 2008588993
May 2008378769
Jun 2008448851
Jul 2008529958
Aug 20085517353
Sep 2008698460
Oct 20086610373
Nov 2008122117119
Dec 200810811581
Jan 2009105138120
Feb 2009112197114
Mar 2009142218145
Apr 200981134126
May 2009109136110
Jun 2009929991
Jul 2009867973
Aug 200984117103
Sep 200911010977
Oct 2009129107114
Nov 20099810089
Dec 200911010380
Jan 201015510466
Feb 201016510874
Mar 201022216299
Apr 201018015473
May 201013511065
Jun 20101399257
Jul 20101009062
Aug 20108911057
Sep 20108412958
Oct 201016619291
Nov 201013216276
Dec 201010713883
Jan 20111238450
Feb 201110012477
Mar 201111213289
Apr 201193135102
May 2011118138103
Jun 2011736590
Jul 2011817457
Aug 20115910589
Sep 2011105109102
Oct 20118418495
Nov 2011120192119
Dec 201178102116
Jan 201211014195
Feb 201213112369
Mar 20129114982
Apr 201210114091
May 2012649269
Jun 2012655184
Jul 20121117175
Aug 2012785871
Sep 2012616179
Oct 2012526347
Nov 20121086665
Dec 2012826267
Jan 2013883646
Feb 2013624240
Mar 2013826659
Apr 2013823769
May 2013586392
Jun 2013473963
Jul 2013382323
Aug 2013282122
Sep 2013453122
Oct 2013514447
Nov 2013624230
Dec 2013514045
Jan 2014302827
Feb 2014433646
Mar 2014434044
Apr 2014523830
May 2014473851
Jun 2014472543
Jul 2014623146
Aug 2014343730
Sep 2014462951
Oct 2014493226
Nov 2014552037
Dec 2014362741
Jan 2015592648
Feb 2015361927
Mar 2015573228
Apr 2015513432
May 2015393733
Jun 2015342722
Jul 2015433337
Aug 2015592928
Sep 2015492339
Oct 2015433137
Nov 2015562651
Dec 2015361928
Jan 2016524152
Feb 2016343032
Mar 2016341927
Apr 2016572738
May 2016422228
Jun 2016284128
Jul 2016342337
Aug 2016361626
Sep 2016622722
Oct 20163110534
Nov 2016278817
Dec 2016296019
Jan 2017188321
Feb 2017156123
Mar 2017179234
Apr 2017126623
May 2017265221
Jun 2017173920
Jul 2017176631
Aug 2017104425
Sep 2017115728
Oct 2017385041
Nov 2017126438
Dec 2017153929
Jan 2018226419
Feb 2018134223
Mar 2018115739
Apr 2018105117
May 201894419
Jun 201894927
Jul 201892414
Aug 201863412
Sep 2018144438
Oct 2018133821
Nov 201895325
Dec 201837238
Jan 20193433
Feb 20194643
Mar 20197433
Apr 201947101
May 20194273
Jun 20196187
Jul 20195457
Aug 20194313
Sep 20193723
Oct 20194435
Nov 20195673
Dec 20194865
Jan 20206933
Feb 20202944
Mar 20206921
Apr 20203732
May 20203211
Jun 20203701
Jul 20202810
Aug 20203211
Sep 20202731
Oct 20204411
Nov 20206822
Dec 20205132
Jan 202149144
Feb 202133107

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 31 (1)
Drug Metabolism and Disposition
Vol. 31, Issue 1
1 Jan 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Metabolism of Clopidogrel Is Catalyzed by Human Cytochrome P450 3A and Is Inhibited by Atorvastatin
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Metabolism of Clopidogrel Is Catalyzed by Human Cytochrome P450 3A and Is Inhibited by Atorvastatin

Thomas A. Clarke and Lucy A. Waskell
Drug Metabolism and Disposition January 1, 2003, 31 (1) 53-59; DOI: https://doi.org/10.1124/dmd.31.1.53

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

The Metabolism of Clopidogrel Is Catalyzed by Human Cytochrome P450 3A and Is Inhibited by Atorvastatin

Thomas A. Clarke and Lucy A. Waskell
Drug Metabolism and Disposition January 1, 2003, 31 (1) 53-59; DOI: https://doi.org/10.1124/dmd.31.1.53
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • In Vivo Functional Effects of CYP2C9 M1L
  • Clearance pathways: fevipiprant with probenecid perpetrator
  • Predicting Volume of Distribution from In Vitro Parameters
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics